Organized in coordination between the  University of Geneva Faculty of Medicine and the Geneva University Hospitals, Switzerland. Preliminary program as of 13.03.2025

Monday, April 7th 2025  

8.00       Registration Sponsors

9:00      Registration Participants

10.00     Welcome Note 

Organizers of the symposium

Antoine Geissbühler, Dean of the Medical Faculty, University of Geneva

Opening lectures (Keynote)

Chairs : Arnaud Didierlaurent, Isabella Eckerle 

10.15    The current landscape of emerging viruses: WHO’s perspective 

Maria van Kerkhove, WHO, Switzerland

10.55      The current landscape of new vaccines and vaccine innovation

Melanie Saville, PATH, United- Kingdom

Swiss Initatives for Pandemic Preparedness

Chairs: Laurent Kaiser,  Pauline Vetter

11:40      The Swiss Network for Infectious Diseases Dynamics (SNIDDY)

Christian Althaus, University of Bern, Switzerland

11.50       Pandemic preparedness in Switzerland

Parham Sendi,  Federal Office of Public Health, Switzerland

12.00      The Center for Pathogen Bioinformatics

Aitana Neves, Swiss Institute of Bioinformatics, Switzerland

12.10      Pathoplexus: an open-source database for sharing viral pathogen genomic data

Cornelius Roemer, University of Basel, Switzerland

12.20      Epidemiological surveillance of acute respiratory viral infections at Geneva University Hospitals: Insights  and Innovations 

Marie-Céline Zanella Terrier and Rebecca Grant, University Hospitals of Geneva, Switzerland

12.30     The Swiss national program for the surveillance of swine influenza A viruses in pigs and humans

Julia Lechmann, University of Zurich, Switzerland

12.40 - 14.00 Lunch break

Session I: Arboviruses – in EuropE and on a global scale

Chairs: Gilles Eperon, Camille Escadafal

14.00 Clinical primer Arboviruses – in Europe and on a global scale

Pauline Vetter, University Hospitals of Geneva, Switzerland

14.10 Mosquito surveillance and vector competence in Switzerland

Eva Veronesi, University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Switzerland

14.35 Recent arbovirus circulation in France - Lessons for research, preparedness and response to arboviral emergence

Xavier de Lamballerie, CNR Arbovirus, Marseille, France

15.00 Vaccines against Arboviruses

Anna Durbin, Johns Hopkins Bloomberg School of Public Health (JHSPH), USA

15.25 Molecular Epidemiology of the Ongoing Oropouche Virus Outbreak: Viral Evolution and Ecological Drivers

Felipe Gomes Naveca, Fiocruz, Brazilian Ministry of Health, Brazil

15.50 - 16.15 Coffee break

Session II: Enteroviruses

Chairs: Manuel Schibler, Manel Essaidi-Laiziosi

16.15     Clinical Primer : A fatal case of disseminated enterovirus infection

Arnaud L'Huillier,  University Hospitals of Geneva, Switzerland

16.25  Enteroviruses - harmless fellow passengers or next disease X?

 Heli Harvala, University of Turku, Finland

16.50  Enteroviruses evolution and diversity

Emma Hodcroft, Swiss Tropical and Public Health Institute, Switzerland

Session III: Hot topic

Chairs: Alexandra Calmy

17.15       Global health in crisis, and then what?

Karl Blanchet, Geneva Centre for Humanitarian Studies, UNIGE, Switzerland

17.40       Mini-Break

Evening Lectures (Keynote)

Chairs : Pauline Vetter, Christiane Eberhardt  

18.00     Welcome Note

Robert Mardini, Director of the University Hospitals of Geneva, Switzerland

18.10    Lessons learned on Evidence Generation from Small Outbreaks

Jakob Cramer, Coalition for Epidemic Preparedness Innovations (CEPI), United-Kingdom

18.50   There will be no warning for the next pandemic

Justin Lessler, University of North Carolina Gillings School of Global Public Health, USA

Social Program

19.30      Apero

Tuesday , April 8th 2025

8.00 - 9.00       Registration

Session I: Influenza viruses

Chairs: Ana Rita Goncalves, Benjamin Meyer

9.00         Clinical primer: A Curious Case of Swine Influenza A Virus in Switzerland

Ronald Dijkman, University of Bern, Switzerland

9.10         Influenza Vaccines: Progress and Challenges

Kanta Subbarao, Laval University, Canada

9.35         How innate immunity drives influenza-vaccine induced responses: implications for mRNA-based and H5-targeted vaccines

Robbert Van der Most, VaxxCellence, Belgium

10.00   Prepandemic vaccines for H5N1

Rory de Vries, Erasmus Medical Centre, The Netherlands

10.25 - 11.00      Coffee Break

Session II: Poxviruses

Chairs: Andrew Azman, Helene Buvelot

11.00     Clinical primer : A case of mpox reinfection 

Stefano Musumeci, University Hospitals of Geneva, Switzerland

11.10       Emergence of Mpox in the Post-Smallpox Era

Placide Mbala, National Institute of Biomedical Research, Democratic Republic of Congo

11.35      MPX Clinical Trials : Unraveling a Complex Journey

Alexandra Calmy, University Hospital of Geneva, Switzerland 

12.00    Mpox vaccines from research to public health use 

Kari Johansen, The Public Health Agency, Sweden

12.25   Mpox : the return of Smallpox ?

Laurent Kaiser, University Hospital of Geneva, Switzerland

12.50 -14.00      Lunch Break

Session III: Coronaviruses

Chairs: Natacha Madelon, Olha Puhach 

14.00       Adaptive immune responses are larger and functionally preserved in a COVID-19 hypervaccinated individual

Kilian Schober, University Hospital Erlangen-Nürnberg, Germany

14.15       Viral Evolution and Scientific Leadership in the Global South

Tulio de Oliveira, Stellenbosch University, South Africa

14.40      Dissecting human immunity to a MERS vaccine candidate

Marylyn Addo, University Medical Center Hamburg-Eppendorf, Germany

15.05       Towards a pan-sarbecovirus vaccine to protect against SARS-CoV-2 variants and animal sarbecoviruses without updating

Pamela Bjorkman, California Institute of Technology, USA

15.30  -16.00     Coffee Break

Session IV: Animal vaccination and the One Health Approach

Chairs:  Marylin Addo, Geraldine Blanchard-Rohner

16.00      Preparing for arboviruses in a changing delta

Marion Koopmans, Erasmus Medical Centre, The Netherlands 

16.25     Zoonotic Influenza Viruses: Pandemic risks and One-Health Perspectives

Martin Beer, Friedrich-Loeffler-Institute, Germany

16.50    Animal Vaccination and One Health Approach

Joris Vandeputte, IABS/VacciM, Belgium

17.15      Prospects and approaches for hunting viral spillovers: Nipah virus in Bangladesh as a case study 

Emily Gurley, Johns Hopkins Bloomberg School of Public Health (JHSPH), USA

17:40  Mini Break

Evening Lecture (Keynote)

Chairs: Isabella Eckerle, Arnaud Didierlaurent 

18.00   Emerging viruses & vaccination in times of humanitarian crisis

Jerome Singh, University of Toronto, Canada

Social Program

19.15     Conference dinner

Wednesday, April 9th 2025

8.00 - 9.00       Registration

Session I: Marburg Virus Diseases

Chairs: Frédérique Jacquerioz, Michael Bel 

09.00     Clinical Primer : update on Marburg outbreaks

Frédérique Jacquerioz, University Hospital of Geneva, Switzerland

09.10     Marburg outbreak Rwanda

Eric Seruyange, University of Rwanda, Rwanda

09.35       Treatment trials for Marburg virus

Amanda Rojek, University of Oxford, United-Kingdom

10.00       Genomic and Transmission Dynamics of the 2024 Marburg Virus Outbreak in Rwanda

Raissa Muvunyi, Rwanda Biomedical Centre, Rwanda

10.25      Vaccination against Marburg

Gene G Olinger, University of Texas Medical Branch, USA

10.50 -11.15      Coffee break

Session II: Towards eradication by vaccination

Chairs: Paul-Henri Lambert et Kamel Senouci

11.15      Measles eradication, challenges and perspectives

Peter Strebel, Independant Consultant, Switzerland

11.40       Poxvirus eradication

David Heymann,  London School of Hygiene and Tropical Medicine, United- Kingdom

12.05       Polio eradication

Ondrej Mach, WHO, Switzerland

12.40       Closing Remarks & Farewell

 

           ***

logoHUG.png medecine70.gif